Results 221 to 230 of about 36,553 (257)

Shared sugars – parasite glycan homology in HIV-1 vaccine design

Trends in Parasitology, 2022
Immune tolerance to self-glycans is a host mechanism to avoid autoimmunity, which is exploited by HIV-1 coating its envelope glycoproteins with glycans to evade neutralising antibodies (nAbs). Huettner et al. describe cross-reactivity between Schistosoma mansoni glycans and HIV-1 envelope glycoprotein glycans, suggesting a strategy for induction of HIV-
Lachlan P. Deimel, Quentin J. Sattentau
openaire   +2 more sources

Immunotherapy of tumors with vaccines based on xenogeneic homologous molecules

Anti-Cancer Drugs, 2002
This review summarizes and discusses a new vaccine strategy based on xenogeneic homologous molecules by the breaking of immune tolerance against the growth factors or their receptors associated with tumor growth in a cross-reaction between the xenogeneic homologs and self-molecules. The xenogeneic vaccine may circumvent the fact that few tumor-specific
openaire   +2 more sources

Comparison of the efficacy of rotavirus VLP vaccines to a live homologous rotavirus vaccine in a pig model of rotavirus disease

Vaccine, 2009
Rotavirus-like particles (VLPs) have shown promise as rotavirus vaccine candidates in mice, rabbits and pigs. In pigs, VLP vaccines reduced rotavirus shedding and disease but only when used in conjunction with live attenuated human rotavirus. Using a porcine rotavirus pig model, rotavirus antigen shedding was reduced by up to 40% after vaccination with
El-Attar, Laila   +6 more
openaire   +3 more sources

Anaplasma marginale inactivated vaccine: dose titration against a homologous challenge

Comparative Immunology, Microbiology and Infectious Diseases, 2000
The present study was performed to dose-titrate an Anaplasma marginale experimental immunogen derived from partially purified initial bodies from three geographically different Mexican strains. Three five-bovine groups were inoculated twice on days zero and 21 with A.
S D, Rodríguez   +5 more
openaire   +2 more sources

Assessing the Reactogenicity of Homologous and Heterologous COVID-19 Vaccine Schedules

2023
Introduction: COVID-19 vaccines were considered as the most effective mode to prevent morbidity and mortality from COVID-19. However, similar to other vaccines, adverse events post-vaccination is expected. This reactogenicity to vaccines varies by type of vaccine and vaccine dose and has primarily been studied in clinical trials with homologous dosing ...
openaire   +1 more source

An Attenuated Influenza Virus Vaccine: Protection against Homologous and Heterologous Strains of Virus

Journal of Infectious Diseases, 1977
An effective influenza virus vaccine should be capable of inducing protection against both the homologous strain of virus and the heterologous strains representing antigenic drift. For evaluation of the protection provided by an attenuated influenza virus vaccine, volunteers were immunized intranasally with either placebo or influenza A/England/42/72 ...
J D, Lee   +3 more
openaire   +2 more sources

Mycobacterial and monkeypox homologous epitopes: Building blocks of a robust monkeypox vaccine

Journal of Biosciences
Numerous scientific studies have established that the BCG vaccination reduces susceptibility to bacterial and viral infections, particularly those causing respiratory tract ailments. This effect is partly attributed to the crossreactivity of BCG antigens, which reinforces immunity and presents an important avenue for therapeutic interventions against ...
Shivank, Prajapati   +7 more
openaire   +2 more sources

Immunotherapy of hepatocellular carcinoma with a vaccine based on xenogeneic homologous α fetoprotein in mice

Biochemical and Biophysical Research Communications, 2008
alpha-Fetoprotein (AFP) is a diagnostic marker for the presence of hepatocellular carcinoma, and a potential target for immunotherapy. Unfortunately, the immunity to AFP is presumably difficult to elicit because of immune tolerance acquired during the development of immune system.
Wei, Zhang   +12 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy